APO Research
Talk to an analyst

APO RESEARCH · REPORT

Formulation Development Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Formulation Development Services Market Outlook and Growth Opportunities 2026

1 January 2026217 pages

Choose your research edition.

Industry ResearchFormulation Development Services Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Formulation Development Services Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Formulation Development Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Formulation Development Services Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Formulation Development Services Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Formulation Development Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Formulation Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Formulation Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Formulation Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Formulation Development Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Formulation Development Services market include Coriolis Pharma, Aurigene Pharmaceutical Services, Adragos Pharma, Ascendia Pharmaceuticals, Dalton Pharma Services, Intertek, Suven Pharma, Agno Pharma and SGS SA, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Formulation Development Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Formulation Development Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Formulation Development Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Formulation Development Services market.

Formulation Development Services Segment by Company

Coriolis Pharma

Aurigene Pharmaceutical Services

Adragos Pharma

Ascendia Pharmaceuticals

Dalton Pharma Services

Intertek

Suven Pharma

Agno Pharma

SGS SA

DPT Laboratories Ltd

MedPharm

Octavius Pharma

Pharmaron

CuriRx, Inc.

LGM pharma

Avivia BV

Corealis

Losan Pharma

Evonik Health Care

Lonza

Alcami

Scantox

Formulation Development Services Segment by Type

Food and Beverage Formula Development

Drug Formula Development

Cosmetic Formula Development

Health Care Product Formula Development

Others

Formulation Development Services Segment by Application

Large Enterprises

Small and Medium Enterprises

Formulation Development Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Formulation Development Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Formulation Development Services key companies, revenue, market share, and recent developments.

3. To split the Formulation Development Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Formulation Development Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Formulation Development Services significant trends, drivers, influence factors in global and regions.

6. To analyze Formulation Development Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Formulation Development Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Formulation Development Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Formulation Development Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Formulation Development Services industry.

Chapter 3: Detailed analysis of Formulation Development Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Formulation Development Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Formulation Development Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Formulation Development Services Industry Trends Table 2. Formulation Development Services Industry Drivers Table 3. Formulation Development Services Industry Opportunities and Challenges Table 4. Formulation Development Services Industry Restraints Table 5. Global Formulation Development Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Formulation Development Services Revenue Share by Company (2021-2026) Table 7. Global Formulation Development Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Formulation Development Services Key Company Manufacturing Base & Headquarters Table 9. Global Formulation Development Services Company, Product Type & Application Table 10. Global Formulation Development Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Formulation Development Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Food and Beverage Formula Development Table 15. Significant Companies of Drug Formula Development Table 16. Significant Companies of Cosmetic Formula Development Table 17. Significant Companies of Health Care Product Formula Development Table 18. Significant Companies of Others Table 19. Global Formulation Development Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Formulation Development Services Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Formulation Development Services Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Formulation Development Services Sales Value Share by Type (2021-2026) Table 23. Global Formulation Development Services Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Large Enterprises Table 25. Significant Companies of Small and Medium Enterprises Table 26. Global Formulation Development Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Formulation Development Services Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Formulation Development Services Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Formulation Development Services Sales Value Share by Application (2021-2026) Table 30. Global Formulation Development Services Sales Value Share by Application (2027-2032) Table 31. Global Formulation Development Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Formulation Development Services Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Formulation Development Services Sales Value Share by Region (2021-2026) Table 34. Global Formulation Development Services Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Formulation Development Services Sales Value Share by Region (2027-2032) Table 36. Global Formulation Development Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Formulation Development Services Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Formulation Development Services Sales Value Market Share by Country (2021-2026) Table 39. Global Formulation Development Services Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Formulation Development Services Sales Value Market Share by Country (2027-2032) Table 41. Coriolis Pharma Company Information Table 42. Coriolis Pharma Business Overview Table 43. Coriolis Pharma Formulation Development Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Coriolis Pharma Formulation Development Services Product Portfolio Table 45. Coriolis Pharma Recent Development Table 46. Aurigene Pharmaceutical Services Company Information Table 47. Aurigene Pharmaceutical Services Business Overview Table 48. Aurigene Pharmaceutical Services Formulation Development Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Aurigene Pharmaceutical Services Formulation Development Services Product Portfolio Table 50. Aurigene Pharmaceutical Services Recent Development Table 51. Adragos Pharma Company Information Table 52. Adragos Pharma Business Overview Table 53. Adragos Pharma Formulation Development Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Adragos Pharma Formulation Development Services Product Portfolio Table 55. Adragos Pharma Recent Development Table 56. Ascendia Pharmaceuticals Company Information Table 57. Ascendia Pharmaceuticals Business Overview Table 58. Ascendia Pharmaceuticals Formulation Development Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Ascendia Pharmaceuticals Formulation Development Services Product Portfolio Table 60. Ascendia Pharmaceuticals Recent Development Table 61. Dalton Pharma Services Company Information Table 62. Dalton Pharma Services Business Overview Table 63. Dalton Pharma Services Formulation Development Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Dalton Pharma Services Formulation Development Services Product Portfolio Table 65. Dalton Pharma Services Recent Development Table 66. Intertek Company Information Table 67. Intertek Business Overview Table 68. Intertek Formulation Development Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Intertek Formulation Development Services Product Portfolio Table 70. Intertek Recent Development Table 71. Suven Pharma Company Information Table 72. Suven Pharma Business Overview Table 73. Suven Pharma Formulation Development Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Suven Pharma Formulation Development Services Product Portfolio Table 75. Suven Pharma Recent Development Table 76. Agno Pharma Company Information Table 77. Agno Pharma Business Overview Table 78. Agno Pharma Formulation Development Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Agno Pharma Formulation Development Services Product Portfolio Table 80. Agno Pharma Recent Development Table 81. SGS SA Company Information Table 82. SGS SA Business Overview Table 83. SGS SA Formulation Development Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. SGS SA Formulation Development Services Product Portfolio Table 85. SGS SA Recent Development Table 86. DPT Laboratories Ltd Company Information Table 87. DPT Laboratories Ltd Business Overview Table 88. DPT Laboratories Ltd Formulation Development Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. DPT Laboratories Ltd Formulation Development Services Product Portfolio Table 90. DPT Laboratories Ltd Recent Development Table 91. MedPharm Company Information Table 92. MedPharm Business Overview Table 93. MedPharm Formulation Development Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. MedPharm Formulation Development Services Product Portfolio Table 95. MedPharm Recent Development Table 96. Octavius Pharma Company Information Table 97. Octavius Pharma Business Overview Table 98. Octavius Pharma Formulation Development Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Octavius Pharma Formulation Development Services Product Portfolio Table 100. Octavius Pharma Recent Development Table 101. Pharmaron Company Information Table 102. Pharmaron Business Overview Table 103. Pharmaron Formulation Development Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Pharmaron Formulation Development Services Product Portfolio Table 105. Pharmaron Recent Development Table 106. CuriRx, Inc. Company Information Table 107. CuriRx, Inc. Business Overview Table 108. CuriRx, Inc. Formulation Development Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. CuriRx, Inc. Formulation Development Services Product Portfolio Table 110. CuriRx, Inc. Recent Development Table 111. LGM pharma Company Information Table 112. LGM pharma Business Overview Table 113. LGM pharma Formulation Development Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. LGM pharma Formulation Development Services Product Portfolio Table 115. LGM pharma Recent Development Table 116. Avivia BV Company Information Table 117. Avivia BV Business Overview Table 118. Avivia BV Formulation Development Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Avivia BV Formulation Development Services Product Portfolio Table 120. Avivia BV Recent Development Table 121. Corealis Company Information Table 122. Corealis Business Overview Table 123. Corealis Formulation Development Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Corealis Formulation Development Services Product Portfolio Table 125. Corealis Recent Development Table 126. Losan Pharma Company Information Table 127. Losan Pharma Business Overview Table 128. Losan Pharma Formulation Development Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Losan Pharma Formulation Development Services Product Portfolio Table 130. Losan Pharma Recent Development Table 131. Evonik Health Care Company Information Table 132. Evonik Health Care Business Overview Table 133. Evonik Health Care Formulation Development Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Evonik Health Care Formulation Development Services Product Portfolio Table 135. Evonik Health Care Recent Development Table 136. Lonza Company Information Table 137. Lonza Business Overview Table 138. Lonza Formulation Development Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Lonza Formulation Development Services Product Portfolio Table 140. Lonza Recent Development Table 141. Alcami Company Information Table 142. Alcami Business Overview Table 143. Alcami Formulation Development Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Alcami Formulation Development Services Product Portfolio Table 145. Alcami Recent Development Table 146. Scantox Company Information Table 147. Scantox Business Overview Table 148. Scantox Formulation Development Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Scantox Formulation Development Services Product Portfolio Table 150. Scantox Recent Development Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Formulation Development Services Product Image Figure 2. Global Formulation Development Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Formulation Development Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Formulation Development Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Food and Beverage Formula Development Image Figure 8. Drug Formula Development Image Figure 9. Cosmetic Formula Development Image Figure 10. Health Care Product Formula Development Image Figure 11. Others Image Figure 12. Global Formulation Development Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Formulation Development Services Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Formulation Development Services Sales Value Share by Type (2021-2032) Figure 15. Large Enterprises Image Figure 16. Small and Medium Enterprises Image Figure 17. Global Formulation Development Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Formulation Development Services Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Formulation Development Services Sales Value Share by Application (2021-2032) Figure 20. Global Formulation Development Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Formulation Development Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Formulation Development Services Sales Value (2021-2032) & (US$ Million) Figure 23. North America Formulation Development Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Formulation Development Services Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Formulation Development Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Formulation Development Services Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Formulation Development Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Formulation Development Services Sales Value (2021-2032) & (US$ Million) Figure 29. South America Formulation Development Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Formulation Development Services Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Formulation Development Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Formulation Development Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Formulation Development Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Formulation Development Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Food and Beverage Formula Development
  • Drug Formula Development
  • Cosmetic Formula Development
  • Health Care Product Formula Development
  • Others
Applications
  • Large Enterprises
  • Small and Medium Enterprises
Companies covered
  • Coriolis Pharma
  • Aurigene Pharmaceutical Services
  • Adragos Pharma
  • Ascendia Pharmaceuticals
  • Dalton Pharma Services
  • Intertek
  • Suven Pharma
  • Agno Pharma
  • SGS SA
  • DPT Laboratories Ltd
  • MedPharm
  • Octavius Pharma
  • Pharmaron
  • CuriRx, Inc.
  • LGM pharma
  • Avivia BV
  • Corealis
  • Losan Pharma
  • Evonik Health Care
  • Lonza
  • Alcami
  • Scantox

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Formulation Development Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Formulation Development Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Formulation Development Services Market Dynamics
  1. 2.1 Formulation Development Services Industry Trends
  2. 2.2 Formulation Development Services Industry Drivers
  3. 2.3 Formulation Development Services Industry Opportunities and Challenges
  4. 2.4 Formulation Development Services Industry Restraints
3 Formulation Development Services Market by Company
  1. 3.1 Global Formulation Development Services Company Revenue Ranking in 2025
  2. 3.2 Global Formulation Development Services Revenue by Company (2021-2026)
  3. 3.3 Global Formulation Development Services Company Ranking (2024-2026)
  4. 3.4 Global Formulation Development Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Formulation Development Services Company Product Type and Application
  6. 3.6 Global Formulation Development Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Formulation Development Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Formulation Development Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Formulation Development Services Market by Type
  1. 4.1 Formulation Development Services Type Introduction
  2. 4.1.1 Food and Beverage Formula Development
  3. 4.1.2 Drug Formula Development
  4. 4.1.3 Cosmetic Formula Development
  5. 4.1.4 Health Care Product Formula Development
  6. 4.1.5 Others
  7. 4.2 Global Formulation Development Services Sales Value by Type
  8. 4.2.1 Global Formulation Development Services Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Formulation Development Services Sales Value by Type (2021-2032)
  10. 4.2.3 Global Formulation Development Services Sales Value Share by Type (2021-2032)
5 Formulation Development Services Market by Application
  1. 5.1 Formulation Development Services Application Introduction
  2. 5.1.1 Large Enterprises
  3. 5.1.2 Small and Medium Enterprises
  4. 5.2 Global Formulation Development Services Sales Value by Application
  5. 5.2.1 Global Formulation Development Services Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Formulation Development Services Sales Value by Application (2021-2032)
  7. 5.2.3 Global Formulation Development Services Sales Value Share by Application (2021-2032)
6 Formulation Development Services Regional Value Analysis
  1. 6.1 Global Formulation Development Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Formulation Development Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Formulation Development Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Formulation Development Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Formulation Development Services Sales Value (2021-2032)
  7. 6.3.2 North America Formulation Development Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Formulation Development Services Sales Value (2021-2032)
  10. 6.4.2 Europe Formulation Development Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Formulation Development Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Formulation Development Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Formulation Development Services Sales Value (2021-2032)
  16. 6.6.2 South America Formulation Development Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Formulation Development Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Formulation Development Services Sales Value Share by Country, 2025 VS 2032
7 Formulation Development Services Country-level Value Analysis
  1. 7.1 Global Formulation Development Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Formulation Development Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Formulation Development Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Formulation Development Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Formulation Development Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Formulation Development Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Formulation Development Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Formulation Development Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Formulation Development Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Formulation Development Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Formulation Development Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Formulation Development Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Formulation Development Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Formulation Development Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Formulation Development Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Formulation Development Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Formulation Development Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Formulation Development Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Formulation Development Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Formulation Development Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Formulation Development Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Formulation Development Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Formulation Development Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Formulation Development Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Formulation Development Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Formulation Development Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Formulation Development Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Formulation Development Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Formulation Development Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Formulation Development Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Formulation Development Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Formulation Development Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Formulation Development Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Formulation Development Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Formulation Development Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Coriolis Pharma
  2. 8.1.1 Coriolis Pharma Company Information
  3. 8.1.2 Coriolis Pharma Business Overview
  4. 8.1.3 Coriolis Pharma Formulation Development Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Coriolis Pharma Formulation Development Services Product Portfolio
  6. 8.1.5 Coriolis Pharma Recent Developments
  7. 8.2 Aurigene Pharmaceutical Services
  8. 8.2.1 Aurigene Pharmaceutical Services Company Information
  9. 8.2.2 Aurigene Pharmaceutical Services Business Overview
  10. 8.2.3 Aurigene Pharmaceutical Services Formulation Development Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aurigene Pharmaceutical Services Formulation Development Services Product Portfolio
  12. 8.2.5 Aurigene Pharmaceutical Services Recent Developments
  13. 8.3 Adragos Pharma
  14. 8.3.1 Adragos Pharma Company Information
  15. 8.3.2 Adragos Pharma Business Overview
  16. 8.3.3 Adragos Pharma Formulation Development Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Adragos Pharma Formulation Development Services Product Portfolio
  18. 8.3.5 Adragos Pharma Recent Developments
  19. 8.4 Ascendia Pharmaceuticals
  20. 8.4.1 Ascendia Pharmaceuticals Company Information
  21. 8.4.2 Ascendia Pharmaceuticals Business Overview
  22. 8.4.3 Ascendia Pharmaceuticals Formulation Development Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ascendia Pharmaceuticals Formulation Development Services Product Portfolio
  24. 8.4.5 Ascendia Pharmaceuticals Recent Developments
  25. 8.5 Dalton Pharma Services
  26. 8.5.1 Dalton Pharma Services Company Information
  27. 8.5.2 Dalton Pharma Services Business Overview
  28. 8.5.3 Dalton Pharma Services Formulation Development Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dalton Pharma Services Formulation Development Services Product Portfolio
  30. 8.5.5 Dalton Pharma Services Recent Developments
  31. 8.6 Intertek
  32. 8.6.1 Intertek Company Information
  33. 8.6.2 Intertek Business Overview
  34. 8.6.3 Intertek Formulation Development Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Intertek Formulation Development Services Product Portfolio
  36. 8.6.5 Intertek Recent Developments
  37. 8.7 Suven Pharma
  38. 8.7.1 Suven Pharma Company Information
  39. 8.7.2 Suven Pharma Business Overview
  40. 8.7.3 Suven Pharma Formulation Development Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Suven Pharma Formulation Development Services Product Portfolio
  42. 8.7.5 Suven Pharma Recent Developments
  43. 8.8 Agno Pharma
  44. 8.8.1 Agno Pharma Company Information
  45. 8.8.2 Agno Pharma Business Overview
  46. 8.8.3 Agno Pharma Formulation Development Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Agno Pharma Formulation Development Services Product Portfolio
  48. 8.8.5 Agno Pharma Recent Developments
  49. 8.9 SGS SA
  50. 8.9.1 SGS SA Company Information
  51. 8.9.2 SGS SA Business Overview
  52. 8.9.3 SGS SA Formulation Development Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SGS SA Formulation Development Services Product Portfolio
  54. 8.9.5 SGS SA Recent Developments
  55. 8.10 DPT Laboratories Ltd
  56. 8.10.1 DPT Laboratories Ltd Company Information
  57. 8.10.2 DPT Laboratories Ltd Business Overview
  58. 8.10.3 DPT Laboratories Ltd Formulation Development Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 DPT Laboratories Ltd Formulation Development Services Product Portfolio
  60. 8.10.5 DPT Laboratories Ltd Recent Developments
  61. 8.11 MedPharm
  62. 8.11.1 MedPharm Company Information
  63. 8.11.2 MedPharm Business Overview
  64. 8.11.3 MedPharm Formulation Development Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MedPharm Formulation Development Services Product Portfolio
  66. 8.11.5 MedPharm Recent Developments
  67. 8.12 Octavius Pharma
  68. 8.12.1 Octavius Pharma Company Information
  69. 8.12.2 Octavius Pharma Business Overview
  70. 8.12.3 Octavius Pharma Formulation Development Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Octavius Pharma Formulation Development Services Product Portfolio
  72. 8.12.5 Octavius Pharma Recent Developments
  73. 8.13 Pharmaron
  74. 8.13.1 Pharmaron Company Information
  75. 8.13.2 Pharmaron Business Overview
  76. 8.13.3 Pharmaron Formulation Development Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pharmaron Formulation Development Services Product Portfolio
  78. 8.13.5 Pharmaron Recent Developments
  79. 8.14 CuriRx, Inc.
  80. 8.14.1 CuriRx, Inc. Company Information
  81. 8.14.2 CuriRx, Inc. Business Overview
  82. 8.14.3 CuriRx, Inc. Formulation Development Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CuriRx, Inc. Formulation Development Services Product Portfolio
  84. 8.14.5 CuriRx, Inc. Recent Developments
  85. 8.15 LGM pharma
  86. 8.15.1 LGM pharma Company Information
  87. 8.15.2 LGM pharma Business Overview
  88. 8.15.3 LGM pharma Formulation Development Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 LGM pharma Formulation Development Services Product Portfolio
  90. 8.15.5 LGM pharma Recent Developments
  91. 8.16 Avivia BV
  92. 8.16.1 Avivia BV Company Information
  93. 8.16.2 Avivia BV Business Overview
  94. 8.16.3 Avivia BV Formulation Development Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Avivia BV Formulation Development Services Product Portfolio
  96. 8.16.5 Avivia BV Recent Developments
  97. 8.17 Corealis
  98. 8.17.1 Corealis Company Information
  99. 8.17.2 Corealis Business Overview
  100. 8.17.3 Corealis Formulation Development Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Corealis Formulation Development Services Product Portfolio
  102. 8.17.5 Corealis Recent Developments
  103. 8.18 Losan Pharma
  104. 8.18.1 Losan Pharma Company Information
  105. 8.18.2 Losan Pharma Business Overview
  106. 8.18.3 Losan Pharma Formulation Development Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Losan Pharma Formulation Development Services Product Portfolio
  108. 8.18.5 Losan Pharma Recent Developments
  109. 8.19 Evonik Health Care
  110. 8.19.1 Evonik Health Care Company Information
  111. 8.19.2 Evonik Health Care Business Overview
  112. 8.19.3 Evonik Health Care Formulation Development Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Evonik Health Care Formulation Development Services Product Portfolio
  114. 8.19.5 Evonik Health Care Recent Developments
  115. 8.20 Lonza
  116. 8.20.1 Lonza Company Information
  117. 8.20.2 Lonza Business Overview
  118. 8.20.3 Lonza Formulation Development Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Lonza Formulation Development Services Product Portfolio
  120. 8.20.5 Lonza Recent Developments
  121. 8.21 Alcami
  122. 8.21.1 Alcami Company Information
  123. 8.21.2 Alcami Business Overview
  124. 8.21.3 Alcami Formulation Development Services Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Alcami Formulation Development Services Product Portfolio
  126. 8.21.5 Alcami Recent Developments
  127. 8.22 Scantox
  128. 8.22.1 Scantox Company Information
  129. 8.22.2 Scantox Business Overview
  130. 8.22.3 Scantox Formulation Development Services Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Scantox Formulation Development Services Product Portfolio
  132. 8.22.5 Scantox Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst